๐‰๐ฎ๐›๐š ๐“๐ž๐š๐œ๐ก๐ข๐ง๐  ๐‡๐จ๐ฌ๐ฉ๐ข๐ญ๐š๐ฅ: ๐“๐ก๐ž ๐†๐จ๐ฏ๐ž๐ซ๐ง๐š๐ง๐œ๐ž ๐๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐’๐ฎ๐๐š๐ง ๐Œ๐ฎ๐ฌ๐ญ ๐€๐ง๐ฌ๐ฐ๐ž๐ซ

Photo Courtesy of Juba Teaching Hospital

Juba Teaching Hospital (JTH) was established in 1975 under the then Regional Government of Sudan and was intended to function alongside the University of Juba as the Southern autonomous regionโ€™s principal teaching and referral hospital. It was designed to serve a dual purpose: providing advanced specialist healthcare while training future generations of health professionals.

Over time, however, the institutional environment that sustained the hospital weakened. Public financing declined, management increasingly shifted toward crisis response, and following South Sudan’s independence, JTH became a department within the National Ministry of Health. Like many public institutions, it came to rely on a central government budget that is often inadequate and supplemented by international Non-Governmental Organizations (NGOs), development partners, and humanitarian actors.

These realities have created a persistent dilemma. JTH is expected to function simultaneously as a national referral hospital, a teaching institution, and a center for specialized medical services, yet it operates within administrative and financial systems that were never designed to support such a complex mandate. As a result, public expectations frequently exceed the hospital’s capacity to deliver.

This challenge has fuelled a recurring debate about the future governance of JTH. Some argue that the hospital should remain under the National Ministry of Health, while others advocate transferring it to the University of Juba because of its teaching role. A third group calls for presidential intervention through executive action to address the hospital’s longstanding governance challenges.

Although these proposals differ in form, they are united by a common assumption: that changing who exercises authority over JTH will solve its problems. Yet this assumption overlooks the true nature of the challenge.

The debate is often framed as a choice between the Ministry of Health and the University of Juba, but such framing oversimplifies the issue. If the hospital remains under the Ministry without broader reform, it will continue to face the same bureaucratic constraints that have historically limited its effectiveness. If it is transferred to the University without reform, it merely exchanges one administrative hierarchy for another. In either scenario, the underlying governance problem remains intact.

The hospital would still operate within rigid public-sector systems governing recruitment, remuneration, procurement, budgeting, and institutional decision-making. Its leadership would continue to have limited flexibility to respond to operational emergencies, attract and retain specialized personnel, manage revenue effectively, or implement performance-based management systems. Changing the reporting line may alter who signs official correspondence, but it does not necessarily alter how the institution functions.

The call for presidential intervention similarly recognizes an important truth: meaningful reform often requires political will at the highest levels of government. However, political will and institutional reform are not the same thing. Presidential decrees and administrative directives can initiate change, appoint leadership, reassign responsibilities, and signal commitment, but they cannot by themselves resolve the structural challenges that have constrained JTH for decades.

Executive action is inherently temporary. What is created through a decree today can be amended or reversed tomorrow. More importantly, administrative directives cannot adequately address complex questions of financial management, procurement authority, employment structures, institutional accountability, and corporate governance. These matters require a durable legal framework rather than administrative discretion.

History repeatedly demonstrates that reforms dependent on individual leaders rarely outlast them. Strong national institutions derive their stability from law, not personalities. A presidential decree may therefore serve as an important catalyst for reform when a competent and good-willed individual is appointed, but it cannot substitute for the legislation required to make that reform enduring.

The crisis at JTH is therefore not fundamentally a crisis of ownership, reporting lines, or ministerial control. It is a crisis of institutional design. The hospital’s core challenge is not the absence of a new supervisor but the absence of a robust statutory foundation to support its complex mandate.

A modern national referral and teaching hospital is too important to be governed primarily through administrative arrangements that can shift with changes in leadership, ministerial priorities, or political circumstances. Such an institution requires a clear legal framework defining its powers, governance structures, accountability mechanisms, financial authority, and relationship with the state. Without such a foundation, any gains achieved through administrative action remain vulnerable, incomplete, and ultimately reversible.

For this reason, the most sustainable solution for Juba Teaching Hospital is not another administrative transfer but its establishment through a dedicated Act of Parliament. Such legislation would transform the hospital from a conventional government department into a legally constituted public institution with clearly defined powers, responsibilities, and accountability mechanisms. It would provide the foundation for long-term institutional stability while preserving public accountability.

A good statutory framework could grant JTH greater financial and operational flexibility, including the authority to retain and reinvest approved revenues, implement more responsive systems for recruiting and retaining specialized health professionals, and operate under an independent governing board. Such a board could bring together representatives from the Ministry of Health, the University of Juba, professional bodies, and other key stakeholders.

Most importantly, these arrangements would be protected by law rather than administrative discretion. The hospital’s governance and performance would no longer depend on the preferences or goodwill of any particular minister, vice chancellor, or president.

South Sudan’s development challenge is not merely the formulation of policies but the creation of institutions that endure beyond political cycles and individual leaders. Juba Teaching Hospital presents a critical test of that national aspiration.

The central question is not who should own the hospital, nor whether a ministerial directive or presidential decree can produce temporary improvements. The real question is whether South Sudan is prepared to establish a governance framework capable of sustaining a modern national referral and teaching hospital for generations.

If the answer is yes, then the path forward lies not merely through ministries or executive offices, but through Parliament. The future of Juba Teaching Hospital should be anchored in the certainty of law rather than the uncertainty of administrative discretion. Ownership matters, but in the long run, governance determines institutional performance, accountability, stability, and longevity.

From Gavi 5.0 to 6.0: Will South Sudan Finally Finance Its Vaccines?

As World Immunization Week comes to an end, South Sudan is not merely reflecting on progress; it is actively negotiating its future.

Over recent weeks, national stakeholders, policymakers, and partners have been engaged in dialogue to review performance under Gavi, the Vaccine Alliance 5.0, and to shape priorities for the next phase. This conversation has now reached a decisive point, with the Gavi country team in South Sudan this week for a two-day in-country grant consolidation dialogue that began yesterday and concludes today. It is one I am privileged to be part of.

These are not routine engagements. They are moments of policy direction-setting, where choices made now will determine how this country finances and sustains life-saving vaccines in the years ahead. And yet, at this very moment, there are public health facilities without the Bacillus Calmetteโ€“Guรฉrin (BCG) vaccine. This contrast between high-level dialogue and frontline stockouts should not be ignored. It is not a logistical anomaly. It is a financing signal.

To move from affordability to prioritisation, it is important to recognise that the economics of this issue are straightforward. For approximately $1.9 per child, South Sudan can procure three essential vaccines: the BCG vaccine, the Tetanus-diphtheria vaccine, and the Oral polio vaccine. It is a question of prioritisation. Each year, the total cost of vaccinating children is estimated at under $10 million. In policy terms, this is not a question of affordability. It is a question of prioritisation.

When essential vaccines at this cost are not consistently available, the issue is not whether resources exist, but whether they are being allocated accordingly. What these points point to is a financing model under strain. For years, South Sudanโ€™s immunisation programme has been sustained through external support, particularly from Gavi and other development partners. This model has delivered results, but it was never designed to be permanent.

The governmentโ€™s own Annual Health Sector Performance Report (2024โ€“2025) provides a clear picture of the current financing landscape. Public expenditure on health remains at approximately 2% of the national budget, significantly below the 15% benchmark set under the Abuja Declaration. At the same time, external sources account for nearly half of total health spending.

As external funding begins to plateau or decline, the expected transition to increased domestic financing has not materialized. Instead, the gap is increasingly absorbed through rising household out-of-pocket expenditures. This pattern is not unique to immunization, but its implications are particularly visible here.

Vaccines, which should be among the most protected and predictable health investments, become vulnerable when the system financing them is unstable. This is how financing gaps translate into service gaps.

The same report characterizes the health financing environment as marked by low government allocation, overreliance on external funding, and rising private expenditure. In practical terms, when financing falters, service delivery follows. Therefore, the absence of the BCG vaccine is not an isolated supply issue. It reflects a broader systemic vulnerability in which essential commodities are not adequately secured within domestic financing frameworks.

The consequences are immediate. Without BCG, newborns are exposed to severe forms of tuberculosis (TB), including TB meningitis and disseminated disease, both of which carry high mortality and long-term health implications. These are not distant risks. They are preventable outcomes.

While there is clearly a gap in health financing reform, it is important to recognize that the challenge is no longer one of policy design. Institutional structures to strengthen health financing are already in place. A Health Financing Unit has been established, technical coordination mechanisms are in place, and engagement with parliamentary processes is ongoing. However, the translation of these structures into tangible financing outcomes remains limited.

Budget allocations have not significantly increased. Planned reforms, including innovative financing mechanisms and the development of a national health insurance framework, have not been implemented. Key financing strategies remain underdeveloped or pending. In policy terms, this is an implementation gap. The architecture exists, but execution does not.

Therefore, the transition from Gavi, the Vaccine Alliance 5.0 to 6.0 presents a strategic inflection point. The ongoing in-country dialogues are not simply about reviewing past performance. They are about defining the terms of future engagement, particularly the balance between external support and domestic responsibility. The central question is no longer whether partners will continue to support South Sudanโ€™s immunization programme. The question is whether South Sudan will progressively assume a greater role in financing it.

This aligns with broader global health policy direction. As emphasized by the World Health Organizationโ€™s Director-General, Tedros Adhanom Ghebreyesus, health sovereignty ultimately rests on domestic financing, not as an abstract principle, but as a budgetary commitment. This moment does not call for blame, nor does it diminish the critical role of development partners. It calls for alignment.

External support is most effective when it complements, rather than substitutes, domestic investment. Government financing, in turn, is essential for ensuring sustainability, predictability, and ownership. At its core, the issue is straightforward. If a country cannot consistently allocate resources for vaccines costing $1.9 per child, the constraint is not purely financial. It is strategic.

As World Immunization Week concludes, and as policymakers and partners convene in-country to shape the next phase of immunization strategy, there is a clear opportunity to move from dialogue to decision.

Financing vaccines domestically is not only a technical necessity. It is a signal of commitment to children, to health systems, and to the countryโ€™s long-term development trajectory. For a nationโ€™s priorities are ultimately reflected in its budget. In South Sudanโ€™s case, the cost of demonstrating that priority is both known and modest. The question now is whether it will be acted upon.